SHANGHAI--(BUSINESS WIRE)--EpimAb Biotherapeutics, an emerging Shanghai-based biopharmaceutical company specializing in bispecific antibodies, today announced the appointment of Dr. Xinyi “David” Gu ...
“I know a lot of trading businesses had a good year last year, but this looks like Merrill must have really had it off, contrary to all the press reports and contrary to what I was hearing through the ...
Shortly after the Wall Street Journal disclosed which Merrill executives had been awarded bumper payouts, Gu was served with a subpoena from New York’s attorney general to give a deposition on his ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback